NCT00232011View on ClinicalTrials.gov

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

May 31, 2005

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus Cream 1%

Pimecrolimus cream 1 %

Trial Locations (1)

Unknown

This study is not being conducted in the United States, Various Cities

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY